Medical imaging software developer MIM Software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for more features for its Contour ProtégéAI autocontouring software.
The clearance is for additional contours for use in the head and neck, thorax, prostate, and abdomen, as well as quality improvements to existing contours. Also, Contour ProtégéAI now supports both cloud-hosted and local deployment in the U.S.
